Ginkgo Bioworks Holdings, Inc. (DNA) reported a narrowed loss for the third quarter compared to the previous year. The company's net loss amounted to $56.40 million, equating to $1.08 per share, a significant improvement from the $302.89 million loss, or $6.21 per share, in the same period last year.
Revenue for the quarter saw a substantial increase, rising by 60.7% to $89.05 million, up from $55.43 million in the prior year.
A summary of Ginkgo Bioworks Holdings, Inc.'s earnings (GAAP) is as follows:
- Third quarter earnings: -$56.40 million compared to -$302.89 million last year.
- Earnings per share (EPS) for Q3: -$1.08 compared to -$6.21 last year.
- Revenue for Q3: $89.05 million compared to $55.43 million last year.
The company has provided its full-year revenue guidance, projecting revenues in the range of $215 million to $235 million.
